Feldman-Stewart Deb, Brundage Michael D
Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, Ont., Canada, K7L 3N6.
Patient Educ Couns. 2004 Sep;54(3):265-73. doi: 10.1016/j.pec.2003.09.007.
Decision aids are tools intended to help patients with decisions about their health-care. We have developed three decision aids to help patients with treatment decisions for: locally advanced non-small cell lung cancer (LA-NSCLC), advanced non-small cell lung cancer (A-NSCLC), and early-stage prostate cancer (ES-PC). In developing the aids, we carried out studies to provide them with an empirical basis, and to evaluate their potential for impact. In this paper we report results that challenge common assumptions and typical practice that currently occurs in the development of decision aids. The challenges relate to: how the content of the aid is defined, how the information is presented, how to incorporate decision aids into the dynamic, complex process of making such decisions, and how to evaluate the aids. We conclude that critical appraisal of issues related to the design and implementation of decision aids is required.
决策辅助工具是旨在帮助患者做出医疗保健决策的工具。我们开发了三种决策辅助工具，以帮助患者做出关于以下疾病的治疗决策：局部晚期非小细胞肺癌（LA-NSCLC）、晚期非小细胞肺癌（A-NSCLC）和早期前列腺癌（ES-PC）。在开发这些辅助工具时，我们进行了研究，为它们提供实证依据，并评估其产生影响的潜力。在本文中，我们报告了一些结果，这些结果挑战了决策辅助工具开发中目前常见的假设和典型做法。这些挑战涉及：辅助工具的内容如何定义、信息如何呈现、如何将决策辅助工具纳入做出此类决策的动态复杂过程，以及如何评估这些辅助工具。我们得出结论，需要对与决策辅助工具的设计和实施相关的问题进行批判性评估。
